Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU

Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU

Posted by Adam Awdish on

Pooled Human Serum Off The Clot from Innovative Research was used in the following study:

 

Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU

Lorena Vigón, Javier García-Pérez, Sara Rodríguez-Mora, Montserrat Torres, Elena Mateos, María Castillo de la Osa, Miguel Cervero, Rosa Malo De Molina, Cristina Navarro, María Aránzazu Murciano-Antón, Valentín García-Gutiérrez, Vicente Planelles, José Alcamí, Mayte Pérez-Olmeda, Mayte Coiras and María Rosa López-Huertas

Frontiers in Immunology
September 20, 2021

Clinical symptoms of COVID-19 infection can range anywhere from asymptomatic to severe, even fatal, infections caused by the cytokine storm elicited by the innate immune response. As such, patients with severe COVID-19 infections have been found to have high levels of inflammation markers in their plasma, such as IL-6, ferritin, or CRP. Patients with extremely severe cases, however, have shown low levels of antiviral cytokines, such as IL-2 and IL-12.

In general, among all patients, there is typically an increase in specific memory B cells that target SARS-CoV-2 during the first few months following infection. In theory, this could provide some immunity toward the infection, even in antibody concentrations decline, however, there is not much data in existence to support this claim. In this study, researchers analyzed the immune responses of patients with COVID-19, ranging from mild to critical cases, and quantified their innate immune responses to the infection.

 

Related products available from Innovative Research also include:

Single Donor Human Plasma (Blood Derived)

Human IgG Affinity Purified

Single Donor Human Whole Blood

  • Tags: Human Serum, Pooled Human Serum Off The Clot, Single Donor Human Serum Off The Clot

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!


    Related Posts

    Multiple Site Place-of-Care Manufactured Anti-CD19 CAR-T Cells Induce High Remission Rates in B-cell Malignancy Patients
    Pooled Human AB Serum Plasma Derived from Innovative Research was used in the following...
    Read the Article
    Stability of Alteplase for Ultrasound-Facilitated Catheter-Directed Thrombolysis
    Human tPA ELISA Kit from Innovative Research was used in the following study:   Stabil...
    Read the Article

    ← Older Post Newer Post →

    ×